Avadel Pharmaceuticals plc: Disclosure of Voting Rights under Derivatives

jueves, 29 de enero de 2026, 9:00 am ET1 min de lectura
AVDL--

Avadel Pharmaceuticals has received a notification from Bloomberg regarding a Form 8.3 submission. The notification does not provide further details about the submission, but it appears to be related to voting rights or the acquisition/disposal of relevant securities. Bloomberg is a leading provider of financial data and analytics, and the notification may indicate a change in ownership or trading activity related to Avadel Pharmaceuticals.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios